SEARCH

SEARCH BY CITATION

REFERENCES

  • Andersson H, Bosaeus I. 1981. Hyperoxaluria in malabsorptive states. Urol. Int. 36: 19.
  • Andersson H, Dotevall G, Gillberg G, Jagenburg R, Kock NG. 1971. Absorption studies in patients with Crohn's disease and in patients with ulcerative colitis. Acta Med. Scand. 190: 407410.
  • Aurrand-Lions M, Galland F, Bazin H, Zakharyev VM, Imhof BA, Naquet P. 1996. Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing. Immunity 5: 391405.
  • Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV. 2002. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 277: 3973939748.
  • Barada KA, Kafrouni MI, Khoury CI, Saade NE, Mourad FH, Szabo SS, Nassar CF. 2001. Experimental colitis decreases rat jejunal amino acid absorption: role of capsaicin sensitive primary afferents. Life Sci. 69: 31213131.
  • Berruyer C, Pouyet L, Millet V, Martin FM, LeGoffic A, Canonici A, Garcia S, Bagnis C, Naquet P, Galland F. 2006. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. J. Exp. Med. 203: 28172827.
  • Bonventre JV. 2008. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand. J. Clin. Lab. Invest. Suppl. 241: 7883.
  • Coca SG, Singanamala S, Parikh CR. 2012. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 81: 442448.
  • Cowland JB, Sorensen OE, Sehested M, Borregaard N. 2003. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J. Immunol. 171: 66306639.
  • Desai A, Huang X, Warren JS. 1999. Intracellular glutathione redox status modulates MCP-1 expression in pulmonary granulomatous vasculitis. Lab. Invest. 79: 837847.
  • Fraser JS, Muller AF, Smith DJ, Newman DJ, Lamb EJ. 2001. Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy. Aliment. Pharmacol. Ther. 15: 11311137.
  • Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. 2002. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62: 237244.
  • Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P, Bonventre JV. 2008. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 73: 863869.
  • Hosohata K, Ando H, Fujimura A. 2012. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury. J. Pharmacol. Exp. Ther. 341: 656662.
  • Hosohata K, Ando H, Fujiwara Y, Fujimura A. 2011. Vanin-1: a potential biomarker for nephrotoxicant-induced renal injury. Toxicology 290: 8288.
  • Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M. 1998. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273: 41354142.
  • Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. 2004. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal Physiol. 286: F552563.
  • Jayaraman A, Roberts KA, Yoon J, Yarmush DM, Duan X, Lee K, Yarmush ML. 2005. Identification of neutrophil gelatinase-associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte-secreted protein response to IL-1beta: a proteomic analysis. Biotechnol. Bioeng. 91: 502515.
  • Kelleher SP, Robinette JB, Miller F, Conger JD. 1987. Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failure. Kidney Int. 31: 725730.
  • Krawczeski CD, Goldstein SL, Woo JG, Wang Y, Piyaphanee N, Ma Q, Bennett M, Devarajan P. 2011. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J. Am. Coll. Cardiol. 58: 23012309.
  • Kreisel W, Wolf LM, Grotz W, Grieshaber M. 1996. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 8: 461468.
  • Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. 1989. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795803.
  • Munshi R, Johnson A, Siew ED, Ikizler TA, Ware LB, Wurfel MM, Himmelfarb J, Zager RA. 2011. MCP-1 gene activation marks acute kidney injury. J. Am. Soc. Nephrol. 22: 165175.
  • Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. 1996. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38: 414420.
  • O'Bryan MK, Cheng CY. 1997. Purification and cellular localization of beta2-microglobulin in the testis. Life Sci. 61: 487494.
  • Oikonomou K, Kapsoritakis A, Eleftheriadis T, Stefanidis I, Potamianos S. 2011. Renal manifestations and complications of inflammatory bowel disease. Inflamm. Bowel Dis. 17: 10341045.
  • Pitari G, Malergue F, Martin F, Philippe JM, Massucci MT, Chabret C, Maras B, Dupre S, Naquet P, Galland F. 2000. Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice. FEBS Lett. 483: 149154.
  • Rothfuss KS, Stange EF, Herrlinger KR. 2006. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J. Gastroenterol. 12: 48194831.
  • Saghaei F, Karimi I, Jouyban A, Samini M. 2012. Effects of captopril on the cysteamine-induced duodenal ulcer in the rat. Exp. Toxicol. Pathol. 64: 373377.
  • Schinstock CA, Semret MH, Wagner SJ, Borland TM, Bryant SC, Kashani KB, Larson TS, Lieske JC. 2012. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury. Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfs127.
  • Star RA. 1998. Treatment of acute renal failure. Kidney Int. 54: 18171831.
  • Torrence AE, Brabb T, Viney JL, Bielefeldt-Ohmann H, Treuting P, Seamons A, Drivdahl R, Zeng W, Maggio-Price L. 2008. Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease. Inflamm. Bowel Dis. 14: 480490.
  • Tsujihata M. 2008. Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. Int. J. Urol. 15: 115120.
  • Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. 2006. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal Physiol. 290: F517529.
  • Yamamoto T, Noiri E, Ono Y, Doi K, Negishi K, Kamijo A, Kimura K, Fujita T, Kinukawa T, Taniguchi H, Nakamura K, Goto M, Shinozaki N, Ohshima S, Sugaya T. 2007. Renal L-type fatty acid--binding protein in acute ischemic injury. J. Am. Soc. Nephrol. 18: 28942902.